EICHORCondition: Analgesia · Sponsor: Heron Therapeutics
Phase 3b, open-label single-arm study in which all subjects receive HTX-011 as part of a scheduled non-opioid MMA regimen.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Helen Keller Hospital | Sheffield, Alabama, United States | — |
| Phoenix Clinical Research, LLC | Tamarac, Florida, United States | — |
| Midwest Clinical Research Center, LLC | Dayton, Ohio, United States | — |
| First Surgical Hospital | Bellaire, Texas, United States | — |
| Plano Surgical Hospital | Plano, Texas, United States | — |
| Endeavor Clinical Trials, LLC. | San Antonio, Texas, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03974932